Braidwell »

Heartflow Inc/Sh shares owned by Braidwell

Quarter-by-quarter ownership of Heartflow Inc/Sh shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Heartflow Inc/Sh

Tip: Access up to 7 years of quarterly data

All positions including Heartflow Inc/Sh held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heartflow Inc/Sh by Braidwell

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 50k 33.66

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Heartflow Inc/Sh

Bain Capital Life Sciences Investors
Wellington Management Company
FMR
Baillie Gifford & Co
Schusterman Interests
Vanguard Group
Capital Research and Management Company - Division 3
Bamco
Lord, Abbett & Co
Alliancebernstein
Henderson Group
Summit Partners Public Asset Management
Ensign Peak Advisors
Artisan Partners Limited Partnership
Rtw Investments

View all funds holding Heartflow Inc/Sh